Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2013

Open Access 01-12-2013 | Case report

Pituitary and adrenal involvement in diffuse large B-cell lymphoma, with recovery of their function after chemotherapy

Authors: Yasuhiro Nakashima, Motoaki Shiratsuchi, Ichiro Abe, Yayoi Matsuda, Noriyuki Miyata, Hirofumi Ohno, Motohiko Ikeda, Takamitsu Matsushima, Masatoshi Nomura, Ryoichi Takayanagi

Published in: BMC Endocrine Disorders | Issue 1/2013

Login to get access

Abstract

Background

Diffuse large B-cell lymphoma sometimes involves the endocrine organs, but involvement of both the pituitary and adrenal glands is extremely rare. Involvement of these structures can lead to hypopituitarism and adrenal insufficiency, and subsequent recovery of their function is rarely seen. The present report describes an extremely rare case of pituitary and adrenal diffuse large B-cell lymphoma presenting with hypopituitarism and adrenal insufficiency with subsequent recovery of pituitary and adrenal function after successful treatment of the lymphoma.

Case presentation

A 63-year-old Japanese man was referred to our hospital due to miosis, ptosis, hypohidrosis of his left face, polydipsia and polyuria. 18F-fluorodeoxy glucose positron emission tomography / computed tomography revealed hotspots in the pituitary gland, bilateral adrenal glands and the apex of his left lung. Surgical biopsy from the pituitary lesion confirmed the diagnosis of diffuse large B-cell lymphoma, with lymphoma cells replacing normal pituitary tissue. Endocrine function tests revealed adrenal insufficiency and panhypopituitarism, including a possible affection of the posterior pituitary. Hormone replacement therapy with desmopressin and hydrocortisone was started. Chemotherapy consisted of six courses of R-CHOP (rituximab, cyclophosphamide, vincristine, doxorubicin and prednisolone) and two courses of high-dose methotrexate followed by autologous hematopoietic stem cell transplantation. Subsequently, his pituitary and bilateral adrenal lesions resolved, and serial endocrine function tests showed gradual improvement in pituitary and adrenal function.

Conclusions

The present report describes an extremely rare case of diffuse large B-cell lymphoma with involvement of both the pituitary and bilateral adrenal glands. R-CHOP and high-dose methotrexate therapy followed by autologous hematopoietic stem cell transplantation was quite effective, and panhypopituitarism and adrenal insufficiency improved to almost normal values after successful treatment of the lymphoma with chemotherapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wang XL, Lü ZH, Mu YM, Dou JT, Lu JM, Zhong WW, Pan CY: Diffuse large cell non-Hodgkin lymphoma with pituitary and bilateral adrenal involvement. Intern Med J. 2012, 42 (3): 329-332. 10.1111/j.1445-5994.2011.02691.x.CrossRefPubMed Wang XL, Lü ZH, Mu YM, Dou JT, Lu JM, Zhong WW, Pan CY: Diffuse large cell non-Hodgkin lymphoma with pituitary and bilateral adrenal involvement. Intern Med J. 2012, 42 (3): 329-332. 10.1111/j.1445-5994.2011.02691.x.CrossRefPubMed
2.
go back to reference Yasuda M, Akiyama N, Miyamoto S, Warabi M, Takahama Y, Kitamura M, Yakushiji F, Kinoshita H: Primary sellar lymphoma: intravascular large B-cell lymphoma diagnosed as a double cancer and improved with chemotherapy, and literature review of primary parasellar lymphoma. Pituitary. 2010, 13: 39-47. 10.1007/s11102-009-0196-9.CrossRefPubMed Yasuda M, Akiyama N, Miyamoto S, Warabi M, Takahama Y, Kitamura M, Yakushiji F, Kinoshita H: Primary sellar lymphoma: intravascular large B-cell lymphoma diagnosed as a double cancer and improved with chemotherapy, and literature review of primary parasellar lymphoma. Pituitary. 2010, 13: 39-47. 10.1007/s11102-009-0196-9.CrossRefPubMed
3.
go back to reference Jonkhoff AR, Huijgens PC, Schreuder WO, Teule GJJ, Heimans JJ: Hypophyseal non-Hodgkin’s lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy. J Neurooncol. 1993, 17 (2): 155-158. 10.1007/BF01050217.CrossRefPubMed Jonkhoff AR, Huijgens PC, Schreuder WO, Teule GJJ, Heimans JJ: Hypophyseal non-Hodgkin’s lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy. J Neurooncol. 1993, 17 (2): 155-158. 10.1007/BF01050217.CrossRefPubMed
4.
go back to reference Wolfe SQ, Hood B, Barker J, Benveniste RJ: Primary CNS Lymphoma mimicking pituitary apoplexy: case report. Pituitary. 2009, 12 (1): 76-79. 10.1007/s11102-008-0084-8.CrossRef Wolfe SQ, Hood B, Barker J, Benveniste RJ: Primary CNS Lymphoma mimicking pituitary apoplexy: case report. Pituitary. 2009, 12 (1): 76-79. 10.1007/s11102-008-0084-8.CrossRef
5.
go back to reference Megan Ogilvie C, Payne S, Evanson J, Lister TA, Grossman AB: Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease. Pituitary. 2005, 8: 139-146. 10.1007/s11102-005-4535-1.CrossRefPubMed Megan Ogilvie C, Payne S, Evanson J, Lister TA, Grossman AB: Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease. Pituitary. 2005, 8: 139-146. 10.1007/s11102-005-4535-1.CrossRefPubMed
6.
go back to reference Li JK, Chow CC, Yeung VT, Ko GT, Cockram CS: Adrenal and hypophyseal non-Hodgkin’s lymphoma presenting with panhypopituitarism. Int J Clin Pract. 1998, 52: 513-514.PubMed Li JK, Chow CC, Yeung VT, Ko GT, Cockram CS: Adrenal and hypophyseal non-Hodgkin’s lymphoma presenting with panhypopituitarism. Int J Clin Pract. 1998, 52: 513-514.PubMed
7.
go back to reference The International non-Hodgkin’s Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993, 329: 987-994.CrossRef The International non-Hodgkin’s Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993, 329: 987-994.CrossRef
8.
go back to reference Pekic S, Milicevic S, Colovic N, Colovic M, Popovic V: Intravascular large B-cell lymphoma as a cause of hypopituitarism: gradual and late reversal of hypopituitarism after long-term remission of lymphoma with immunochemotherapy. Endocrine. 2008, 34: 11-16. 10.1007/s12020-008-9109-3.CrossRefPubMed Pekic S, Milicevic S, Colovic N, Colovic M, Popovic V: Intravascular large B-cell lymphoma as a cause of hypopituitarism: gradual and late reversal of hypopituitarism after long-term remission of lymphoma with immunochemotherapy. Endocrine. 2008, 34: 11-16. 10.1007/s12020-008-9109-3.CrossRefPubMed
9.
go back to reference Kenchaiah M, Hyer SL: Diffuse large B-cell non Hodgkin’s lymphoma in a 65-year-old woman presenting with hypopituitarism and recovering after chemotherapy: a case report. J Med Case Reports. 2011, 5: 498-10.1186/1752-1947-5-498.CrossRefPubMedCentral Kenchaiah M, Hyer SL: Diffuse large B-cell non Hodgkin’s lymphoma in a 65-year-old woman presenting with hypopituitarism and recovering after chemotherapy: a case report. J Med Case Reports. 2011, 5: 498-10.1186/1752-1947-5-498.CrossRefPubMedCentral
Metadata
Title
Pituitary and adrenal involvement in diffuse large B-cell lymphoma, with recovery of their function after chemotherapy
Authors
Yasuhiro Nakashima
Motoaki Shiratsuchi
Ichiro Abe
Yayoi Matsuda
Noriyuki Miyata
Hirofumi Ohno
Motohiko Ikeda
Takamitsu Matsushima
Masatoshi Nomura
Ryoichi Takayanagi
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2013
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-13-45

Other articles of this Issue 1/2013

BMC Endocrine Disorders 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.